Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Apple Watch AFib feature becomes first-ever digital tool approved by FDA to evaluate medical devices
Healthcare technology companies can now use AFib findings recorded by an Apple Watch to help demonstrate the effectiveness of their devices to the FDA.
Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology
The use of radial access during PCI procedures is increasing throughout the United States, and new data presented at the SCAI's annual meeting suggest that could be beneficial for patients.
Cardiologists and surgeons perform world’s first robot-assisted TEER
A 62-year-old women presented with severe MR and recurrent heart failure episodes. Initial data suggest the procedure was a success.
Cardiologist Sunil Rao highlights importance of DanGer Shock compared to other cardiogenic shock trials
Sunil Rao, MD, director of interventional cardiology at NYU Langone, says DanGer Shock is a "very, very important study" when it comes to the treatment of cardiogenic shock.
PAD patients face greater risk of death, complications after a heart attack
PAD and CLI patients who show signs of coronary heart disease may benefit from early treatment, according to a new study of nearly 4 million hospitalizations.

Example of a left atrial posterior wall (LAPW) pulmonary vein isolation (PVI) to better treat persistent atrial fibrillation (AFib) using the Abbott electromapping system.

Targeting the left atrial posterior wall during pulsed field ablation fails to improve outcomes

Researchers explored the potential of an alternate way to perform PFA on patients with persistent AFib, presenting their findings live at AF Symposium 2024 in Boston.

February 2, 2024

FDA approved the first transcatheter tricuspid valve (TTVR) replacement device in February 2024, the EVOQUE system from Edwards Lifesciences. The Evoque is the first transcatheter tricuspid valve approved by the FDA. The Evoke the first transcatheter tricuspid cleared in the United States.

Edwards makes history, receives FDA approval for transcatheter tricuspid valve replacement device

The approval, based on positive results from the TRISCEND II trial, represents a significant milestone for the treatment of severe tricuspid regurgitation.

February 2, 2024

Medtronic's PulseSelect Pulsed Field Ablation (PFA) System

Real-world patients now being treated with Medtronic’s PFA system

Medtronic is celebrating the success of its PulseSelect pulsed field ablation product by highlighting its impact on heart patients around the world.

February 1, 2024

Tablet projecting metaphorical medical hologram

AI-powered risk score predicts how heart failure patients will respond to loop diuretics

New research out of Texas could go a long way toward improving care for patients with acute decompensated heart failure.

January 31, 2024

FDA announces Class I recall of more than 250,000 chest drains over safety concerns

According to the FDA, using these devices without following manufacturer recommendations could lead to “serious injuries or death."

January 31, 2024

Philips received U.S. Food and Drug Administration (FDA) clearance for a compact transesophageal echocardiography (TEE) ultrasound transducer. The X11-4t Mini 3D TEE transducer was designed to improve image quality when evaluating certain patient populations, including pediatric patients and adults who present with a heightened risk of complications.

FDA clears smaller 3D TEE transducer for imaging children, high-risk adult patients

The newly approved device is much smaller than previous offerings, helping operators capture 3D images during structural heart evaluations.

January 31, 2024

Farapulse Boston Scientific Pulsed Field Ablation PFA fda approval

FDA approves Boston Scientific’s pulsed field ablation system for AFib

The FDA’s final decision was based largely on positive results from the ADVENT clinical trial, which compared treatment with the Farapulse PFA System to the current standard of care.

January 31, 2024

According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.

SAVR in the TAVR era: Volumes are down, but it remains the go-to choice for certain patient populations

Annual SAVR volumes in the United States decreased by a whopping 44.5% from 2012 to 2022. However, heart teams across the country seem to agree that surgery is a safer, more effective treatment option than TAVR when patients present with bicuspid aortic valves.

January 30, 2024

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Clinical

Apple Watch AFib feature becomes first-ever digital tool approved by FDA to evaluate medical devices

Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology

Cardiologists and surgeons perform world’s first robot-assisted TEER

Cardiologist Sunil Rao highlights importance of DanGer Shock compared to other cardiogenic shock trials

PAD patients face greater risk of death, complications after a heart attack

Around the web